» Articles » PMID: 31565417

Strengthening Strategic Management Approaches to Address Antimicrobial Resistance in Global Human Health: a Scoping Review

Overview
Journal BMJ Glob Health
Specialty Public Health
Date 2019 Oct 1
PMID 31565417
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The development and implementation of national strategic plans is a critical component towards successfully addressing antimicrobial resistance (AMR). This study aimed to review the scope and analytical depth of situation analyses conducted to address AMR in human health to inform the development and implementation of national strategic plans.

Methods: A systematic search of the literature was conducted to identify all studies since 2000, that have employed a situation analysis to address AMR. The included studies are analysed against frameworks for strategic analysis, primarily the PESTELI (Political, Economic, Sociological, Technological, Ecological, Legislative, Industry) framework, to understand the depth, scope and utility of current published approaches.

Results: 10 studies were included in the final review ranging from single country (6) to regional-level multicountry studies (4). 8 studies carried out documentary review, and 3 of these also included stakeholder interviews. 2 studies were based on expert opinion with no data collection. No study employed the PESTELI framework. Most studies (9) included analysis of the political domain and 1 study included 6 domains of the framework. Technological and industry analyses is a notable gap. Facilitators and inhibitors within the political and legislative domains were the most frequently reported. No facilitators were reported in the economic or industry domains but featured inhibiting factors including: lack of ring-fenced funding for surveillance, perverse financial incentives, cost-shifting to patients; joint-stock drug company ownership complicating regulations.

Conclusion: The PESTELI framework provides further opportunities to combat AMR using a systematic, strategic management approach, rather than a retrospective view. Future analysis of existing quantitative data with interviews of key strategic and operational stakeholders is needed to provide critical insights about where implementation efforts should be focussed, and also how to build contingency at the strategic level for agile responses to macro-level environmental influences.

Citing Articles

Power Relations in Optimisation of Therapies and Equity in Access to Antibiotics (PROTEA) Study: investigating the intersection of socio-economic and cultural drivers on antimicrobial resistance (AMR) and its influence on healthcare access and....

Charani E, Dlamini S, Koch A, Singh S, Hodes R, Laxminarayan R Wellcome Open Res. 2024; 9:400.

PMID: 39315357 PMC: 11417457. DOI: 10.12688/wellcomeopenres.20193.1.


Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions.

Cocker D, Birgand G, Zhu N, Rodriguez-Manzano J, Ahmad R, Jambo K Nat Rev Microbiol. 2024; 22(10):636-649.

PMID: 39048837 DOI: 10.1038/s41579-024-01076-4.


Evaluating Antibiotic Treatment Guideline Adherence to Ongoing Antibiotic Stewardship in a Tertiary Care Setting: A Retrospective Observational Study.

Pant S, Corwin A, Adhikari P, Acharya S, Acharya U, Silwal S Can J Infect Dis Med Microbiol. 2024; 2024:6663119.

PMID: 38660495 PMC: 11042908. DOI: 10.1155/2024/6663119.


Mitigating antimicrobial resistance (AMR) using implementation research: a development funder's approach.

Khurana M, Essack S, Zoubiane G, Sreenivasan N, Cordoba G, Westwood E JAC Antimicrob Resist. 2023; 5(2):dlad031.

PMID: 36994233 PMC: 10041058. DOI: 10.1093/jacamr/dlad031.


Antimicrobial stewardship in Latin America: Past, present, and future.

Fabre V, Cosgrove S, Secaira C, Torrez J, Lessa F, Patel T Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e68.

PMID: 36483374 PMC: 9726506. DOI: 10.1017/ash.2022.47.


References
1.
Pham M, Rajic A, Greig J, Sargeant J, Papadopoulos A, McEwen S . A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods. 2015; 5(4):371-85. PMC: 4491356. DOI: 10.1002/jrsm.1123. View

2.
Gelband H, Laxminarayan R . Tackling antimicrobial resistance at global and local scales. Trends Microbiol. 2015; 23(9):524-6. DOI: 10.1016/j.tim.2015.06.005. View

3.
Ardal C, Outterson K, Hoffman S, Ghafur A, Sharland M, Ranganathan N . International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2015; 387(10015):296-307. DOI: 10.1016/S0140-6736(15)00470-5. View

4.
Kakkar M, Chatterjee P, Singh Chauhan A, Grace D, Lindahl J, Beeche A . Antimicrobial resistance in South East Asia: time to ask the right questions. Glob Health Action. 2018; 11(1):1483637. PMC: 6008583. DOI: 10.1080/16549716.2018.1483637. View

5.
Van Nguyen K, Thi Do N, Chandna A, Nguyen T, Pham C, Doan P . Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013; 13:1158. PMC: 4116647. DOI: 10.1186/1471-2458-13-1158. View